<DOC>
	<DOCNO>NCT00607295</DOCNO>
	<brief_summary>1 . Although treatment breast cancer chemotherapy hormonal therapy , urogenital atrophy common , patient seldomly treat several reason . Management problem important improving quality life . 2 . `` Clino-san '' kind vaginal lubricant pH 5 similar pH premenopausal vaginal discharge . After randomization patient , treat Clino-san placebo 3 times/week 12 week . 3 . We check vaginal symptom , vag dryness severity score , ultrasonography baseline , 4 , 8 , 12 week treatment .</brief_summary>
	<brief_title>Efficacy Safety Clino-san Vaginal Dryness Breast Cancer Patients</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Atrophy</mesh_term>
	<criteria>breast cancer patient treat chemotherapy hormonal therapy experience menstruation previous therapy complain vaginal dryness cancer patient severe disease poor compliance</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>chemotherapy</keyword>
	<keyword>hormonal therapy</keyword>
	<keyword>urogenital atrophy</keyword>
</DOC>